AKBA - Akebia Therapeutics, Inc.

QQQ $ 440.60 $ 0.16 (0.04 %)

DIA $ 392.24 $ 2.13 (0.55 %)

SPY $ 518.80 $ 1.36 (0.26 %)

TLT $ 90.10 $ 0.06 (0.07 %)

GLD $ 215.77 $ 1.07 (0.5 %)

Previous Close

$ 1.4

Open

$ 1.20

Bid

$ 1.26 x 2,200

Ask

$ 1.28 x 100

Day's Range

$ 1.07 - $ 1.27

52 Week Range

$ 0.78 - $ 2.48

Volume

2,847,959

Average Volume

Market Cap

286.94M

Beta (5Y Monthly)

$ 1.49

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-14-2024	12-31-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-28-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	03-10-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-09-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-10-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-05-2020	03-31-2020	10-Q
18	03-12-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-08-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	03-26-2019	12-31-2018	10-K
23	11-08-2018	09-30-2018	10-Q
24	08-08-2018	06-30-2018	10-Q
25	05-09-2018	03-31-2018	10-Q
26	03-12-2018	12-31-2017	10-K
27	11-08-2017	09-30-2017	10-Q
28	08-08-2017	06-30-2017	10-Q
29	05-09-2017	03-31-2017	10-Q
30	03-06-2017	12-31-2016	10-K
31	11-09-2016	09-30-2016	10-Q
32	08-08-2016	06-30-2016	10-Q
33	05-05-2016	03-31-2016	10-Q
34	03-14-2016	12-31-2015	10-K
35	11-09-2015	09-30-2015	10-Q
36	08-11-2015	06-30-2015	10-Q
37	05-11-2015	03-31-2015	10-Q
38	03-04-2015	12-31-2014	10-K
39	11-10-2014	09-30-2014	10-Q
40	08-11-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Akebia Therapeutics Q1 2024 GAAP EPS $(0.0...
05/09/2024 11:04:36

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
04/10/2024 12:09:34

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
03/29/2024 16:30:53

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
03/28/2024 17:35:26

HC Wainwright & Co. Maintains Buy on Akebi...
03/28/2024 16:20:48

HC Wainwright & Co. analyst Ed Arce maintains Akebia Therapeutics (NASDAQ:AKBA) with a Buy and raises the price target f...

fda-approves-for-akebia-therapeutics-vafseo-for-kidney-disease-associated-anemia

FDA Approves For Akebia Therapeutics' Vafs...
03/28/2024 13:50:08

The FDA-approved Vafseo tablets by Akebia Therapeutics for managing anemia in adult dialysis patients with chronic kidney disea...

why-rh-shares-are-trading-higher-by-around-9-here-are-20-stocks-moving-premarket

Why RH Shares Are Trading Higher By Around...
03/28/2024 12:21:31

Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results.

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
03/28/2024 12:06:10

Akebia Therapeutics shares are trading hig...
03/28/2024 11:24:19

Reported Earlier, Akebia's Wins FDA Approv...
03/28/2024 05:51:37

Once-Daily Oral HIF-PH Inhibitor Activates Physiologic Response to Manage Anemia Akebia's Launch Strategy Developed to ...

Cintas Reports Upbeat Earnings, Joins PayS...
03/27/2024 14:03:27

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Westport Fuel Systems Shares Are Tradi...
03/26/2024 17:45:27

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

12 Health Care Stocks Moving In Friday's I...
03/15/2024 17:31:09

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
03/15/2024 13:06:20

HC Wainwright & Co. Reiterates Buy on Akeb...
03/15/2024 10:27:15

HC Wainwright & Co. analyst Ed Arce reiterates Akebia Therapeutics (NASDAQ:AKBA) with a Buy and maintains $5 price target.

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
03/14/2024 21:33:37

Recap: Akebia Therapeutics Q4 Earnings
03/14/2024 21:25:13

Akebia Therapeutics Q4 Sales $56.200M Beat...
03/14/2024 20:36:14

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly sales of $56.200 million which beat the analyst consensus estimate of $55....

Earnings Scheduled For March 14, 2024
03/14/2024 09:52:13

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

Earnings Preview For Akebia Therapeutics
03/13/2024 14:05:13